Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.
News Medical on MSN14h
Evidence increasingly links ultra-processed food consumption to weight gainResearch shows that promoting fruits and vegetables isn't enough to combat weight gain, highlighting the significant role of ...
Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...
Click here for more informationWatching your formerly thick hair become thinner over time can be disheartening. It can also ...
Hims & Hers Health, Inc. (HIMS) shares rallied 27.7% in the last trading session to close at $59.18. This move can be attributable to notable volume with a higher number of shares being traded than in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback